Effects of Long-Term Pamidronate Treatment on Bone Density and Fracture Rate in 65 Osteogenesis Imperfecta Patients
Date
2021Author
Gunes, Nilay
Yazan, Hakan
Ozyalvac, Osman Nuri
Yildirim, Timur
Akpinar, Evren
TÜYSÜZ, Beyhan
Akkaya, Dilek Uludag
Metadata
Show full item recordAbstract
Objective: Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous disease characterized by recurrent fractures, blue sclera, and hearing loss. Bisphosphonate treatment has been reported to decrease the annual number of fractures and improve the quality of life in patients with OI. The aim of this study is to evaluate the effect of bisphosphonate treatment in the Turkish OI cohort.
Collections
- Makale [92796]